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In Ontario, Diagnostic Assessment Programs (DAPs) have been implemented to improve the quality of care patients 
receive during the diagnostic phase of the cancer journey.  Patient navigators play a critical role in this model by 
coordinating care and providing information and support to patients and their families.  The objectives of this study 
were 1) to determine whether patient navigation in DAPs is associated with a better patient experience and 2) to examine 
whether patient navigation in DAPs modifies the effect of wait times and patient volumes on patient experience. Data 
reflecting patients’ experience within the DAP were collected via survey and an average experience score was calculated 
for each region. To ascertain the relationship between patient experience, wait times and volumes, correlation 
coefficients were computed between regional patient experience scores and total regional patient volumes and between 
regional patient experience score and regional diagnostic wait times. To understand the impact of navigators on the 
patient experience, the sample was subdivided according to whether or not the respondent reported knowing their 
navigator. Patients who knew their navigator rated their experience significantly better than those who did not. For those 
who did not know their navigator, there was an inverse and significant correlation between patient experience scores and 
wait times; patients in regions with long waits had poorer experience scores overall.  Patients who knew their navigator 
reported consistently good experience regardless of their diagnostic wait. The navigator appears to mitigate the negative 
impact of longer wait times on experience.  
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The journey from suspicion of cancer to a definitive 
diagnosis or rule out can be a confusing and anxious time 
for patients.  Patients with a suspicion of cancer will often 
require numerous tests and visit multiple healthcare 
professionals,1,2 often making transitions from one health 
care provider to another 2,3. To improve the quality of care 
during the diagnostic phase of the cancer journey, Cancer 
Care Ontario (CCO), an agency of the provincial 
government of Ontario and the province’s principal 
adviser on cancer care, supports the development and 
implementation of Diagnostic Assessment Programs 
(DAPs) in all regions across Ontario1,2,3,4. DAPs provide a 
single point of entry for patients to access centralized 
services that can include diagnostic tests, staging and 
comprehensive care. Multidisciplinary health-care teams in 
DAPs work in a collaborative setting to provide high-
quality, evidence-based, patient-centered care and aim to 
minimize system delays. DAP programs rely heavily on a 
model of patient navigation, where a trained professional 
coordinates the care for patients through the system of 
diagnostic testing 2,5. Patient Navigators also provide the 
necessary support and information about cancer to 
patients and their families and refer them to additional 
supportive services (e.g. social work) as required 1,2,3.  
Navigation support in each DAP currently ranges from 0.2 
to 3.8 full time equivalents (FTE) of nursing staff. The 
majority (95%) of patient navigators working in Ontario 
DAPs are nurses.  
The published literature suggests that one of the strongest 
known benefits of patient navigation during the diagnostic 
phase of care is in helping patients complete their cancer 
screening 6.  Researchers in the United States have even 
demonstrated cost savings associated with the improved 
diagnostic resolution achieved with patient navigation 7. 
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There is also evidence to suggest that navigation has an 
impact on patient experience and quality of life 8. A 
retrospective cohort study of head and neck cancer 
patients with access to patient navigators reported that 
patients felt less stressed about their future, their body 
image, and communication or social issues arising from 
their cancer, and had greater satisfaction with the care they 
received during their cancer treatment 8.  In a cross-
sectional study of patient perceptions of navigation, 98% 
of patients who were assigned a navigator reported being 
grateful that the service was provided, and up to 95% 
agreed that navigation was an important addition to 
diagnostic care9.  When the satisfaction levels of cancer 
patients with and without a navigator have been directly 
compared, multiple studies have reported higher levels of 
satisfaction in patients with a navigator compared to those 
receiving conventional care 10,2.  The evidence for a 
positive impact of patient navigation on satisfaction is not, 
however, undisputed.  One study that looked at 
satisfaction measures before and after cancer care found 
no relationship between patient navigation and overall 
patient satisfaction 11 but a possible role for navigation in 
addressing the barriers that are known to affect patient 
experience 11.  
 
One of the key mechanisms by which patient navigators 
appear to improve patient satisfaction is through patient 
education.  Navigators routinely play an education role, in 
which they enable patients to better understand their 
medical condition and help them manage their anxiety 1. 
Those cancer patients who understand information 
relating to their own health have been found to have less 
stress and to be more confident and knowledgeable, 
allowing them to more easily participate in the processes 
of care and recovery 12.  In a retrospective cohort study of 
breast cancer patients, navigators were seen to increase 
patient appreciation as well as knowledge of their personal 
health and the importance of post-operative or post-
treatment practices 13.   In this study, the use of a navigator 
increased adherence to a set of pre-determined quality 
indicators by 27%, significantly improving the rate of 
follow-up mammograms, systemic therapy use and 
survivorship quality of life 13. Interestingly, patient 
navigation has been found to continue to enhance patient 
self-care and health practices beyond the termination of 
the patient-navigator relationship as a result of increased 
patient knowledge 13.  
 
Waiting for diagnostic results is difficult and a patient’s 
healthcare experience can be affected by the length of time 
that they have to wait throughout their cancer journey 
14,15,16,17. Patient navigation programs in cancer care have 
been found to provide immediate improvements in both 
wait time and access to care 2. A Multidisciplinary Lung 
Cancer Clinic (MLCC) in the United States that 
implemented nurse navigators managed to decrease the 
time from diagnosis to treatment or therapy from 1 to 3 
months, down to 14 days in 92% of lung cancer patients 
10. The same MLCC reported a large increase in patient 
satisfaction after the introduction of nurse navigators, 
regardless of diagnosis or disease outcome 10.  Similarly, a 
study of the effectiveness of patient navigators found that 
among patients who were randomly assigned to a 
navigator, only 6% of those with an abnormal 
mammogram did not have a definitive diagnosis after 60 
days, compared to 22% among those randomly assigned to 
the group without access to a navigator 18. This decrease in 
wait time was found to be associated with lower anxiety 
and greater patient satisfaction, regardless of the result of 
the diagnosis 18. A study of wait times for breast cancer 
care in Canadian regional cancer centers found that the 
utilization of nurse navigators to streamline care and 
provide information and support to patients significantly 
decreased wait time for surgery and increased patient 
satisfaction through enhanced care and communication 19. 
 
Research to date suggests that patient navigation may 
enhance a program’s capacity to meet demands for care 
and several studies have focused on the role of navigation 
in managing high volumes of patients in a clinical program 
1,10.  Navigators have been described as particularly helpful 
for managing complex cases in high volume situations, 
especially in organizing multidisciplinary work 1. It has also 
been found that navigators allow programs to provide care 
to more patients. For instance, a study of lung cancer 
patients found that following the introduction of a 
navigator to coordinate services for patients, 48% more 
patients could be seen and treated at the cancer center 10.  
It is appreciated that this greater capacity may result in 
higher patient volumes, which may negatively affect the 
amount of navigation time per patient.  However there is a 
dearth of research assessing the impact of patient volume 
on experience or satisfaction with care during the 
diagnostic phase of the cancer journey.   
 
Given the extant literature that demonstrates the link 
between navigation and greater patient satisfaction, 
decreased wait times, and an ability to manage greater 
patient volumes, this study aimed to determine the 
relationship between patient experience and navigation, 
wait times and patient volumes for patients undergoing 
diagnostic assessment for suspected lung cancer in DAPs 
in Ontario.  The objectives of this study were 1) to 
determine whether patient navigation in DAPs is 
associated with a better patient experience and 2) to 
examine whether patient navigation in DAPs modifies the 
effect of wait times and patient volumes on patient 




One year of data from the DAP provincial Patient 
Experience Survey (PES), collected from July 1, 2012 to 
June 30, 2013 was used for this study.  The survey targets 
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patients undergoing diagnostic testing for suspicion of 
thoracic/lung cancer in DAPs across the Province of 
Ontario. Administrative data regarding patient wait time 
from referral to diagnosis was collected from all 
thoracic/lung DAPs for the same time period.  The unit of 
analysis was the Regional Cancer Program (or ‘region’), of 
which there are 14 in Ontario.  
 
Patient Experience Survey 
DAP patient experience scores were derived from the 
PES, an anonymous, 18 item, retrospective survey 
routinely used in all 15 lung/thoracic DAPs across the 14 
regional cancer programs in Ontario.  The survey asks a 
variety of questions about DAP patients’ experience, 
including information, communication, and emotional 
support, as well as their relationship with the DAP patient 
navigator.  Thirteen questions relate specifically to the 
patient’s experience in the Diagnostic Assessment 
Program.  The remainder includes 2 demographic 
questions, 2 questions about the patient’s levels of anxiety 
and fear and 1 question asking whether the patient knew 
their navigator.  The DAP PES was adapted from the 
Ambulatory Oncology Patient Satisfaction Survey 
(AOPSS), a survey developed and validated in Canada by 
the National Research Corporation 20 and used in at least 
two provinces across the country.  Ten of the 18 PES 
items were derived from the AOPSS, although slightly 
modified after face validity testing for the purpose of using 
them with the DAP patient population. A list of the survey 
questions can be found in Appendix 1. 
 
The PES is routinely administered by DAP Navigators or 
nurses to each patient visiting a DAP.  There is no 
systematic follow-up for compliance except for the 
encouragement of the Navigator or nurse to complete the 
survey at the end of their diagnostic testing.  Completed 
surveys are returned directly to Cancer Care Ontario 
online or by mail.  This work reflects the data from 
surveys received between July 1, 2012 and June 30, 2013.   
 
A composite patient experience rating was calculated for 
each patient by scoring the responses from each of the 13 
questions that addressed aspects of patient experience on a 
4-point scale and adjusting for the number of patient 
experience questions answered. A regional score was then 
derived based on the average composite score among 
patients in each region for the entire time period in 
question.  
 
The survey also contains one question asking patients to 
identify whether or not they knew their Navigator and two 
demographic questions regarding the patient’s level of 
education and age.  The question of whether the patient 
knew their Navigator was used as a stratifying variable and 
in this study was considered a proxy for whether the 
patient used the services of the Navigator.  The 
demographic variables were used to determine the 
comparability between those who knew their Navigator 
and those who did not.    
 
Administrative Data  
Time points for wait time calculations and patient volumes 
from July 1, 2012 to June 30, 2013 were obtained from 
administrative datasets held by Cancer Care Ontario. The 
diagnostic wait time interval (from referral to diagnosis) 
was calculated as the time from referral to a DAP to the 
date on which a pathology or imaging report confirmed a 
patient’s diagnosis or rule out of cancer 21. For each 
region, the 50th, 75th and 90th percentiles of the wait time 
interval were studied to understand regional variation in 
diagnostic wait times. Patient volumes were also 
calculated, reflecting the total number of patients in each 
region who received care from a DAP during the year of 
interest.   
 
Analyses 
In order to investigate the representativeness of the survey 
respondents with respect to the overall DAP population of 
patients, patient age from the DAP administrative data was 
compared to self-reported demographic information from 
the patient experience survey.  A between-group 
comparison was also performed to look at differences 
between the group who knew their Navigator and those 
who did not, focusing on age and level of education.  
These demographic analyses were undertaken utilizing chi 
square tests to determine if there were significant 
differences in the distribution of the data between the 
groups. 
 
It was not possible to link survey data to administrative 
data at the patient level because the survey was anonymous 
and no patient identifiers were available.  However, survey 
and administrative data were aggregated and linked at the 
regional level.  As a result, all analysis involving survey data 
and other DAP data (i.e. volumes, wait times) were 
performed with the region as the unit of analysis (n=14).   
 
In order to ascertain the relationship between patient 
experience, wait times and volumes, Pearson correlation 
coefficients were computed between regional patient 
experience scores and total regional patient volumes and 
between regional patient experience score and the 50th, 
75th and 90th percentile of regional diagnostic wait time.  
 
To understand the impact of navigation on the patient 
experience, the sample was subdivided according to 
whether or not the respondent reported knowing their 
Navigator. The navigation and non-navigation groups 
were analyzed separately using Pearson correlations to 
explore the relationship between wait times or volumes 
and patient experience ratings. These two groups were also 
compared using a Student’s t-test to determine the overall 
effect of navigation on patient experience rating. 
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Results 
 
Patient Experience Survey Response Rate 
The Patient Experience Survey (PES) had an overall 
response rate of 20.9% (1,325 PES responses received out 
of a total of 6,327 DAP patients in that time period) and 
response rates varied by region from 5 to 44%.  Among 
those surveys received, the completion rate was 97.5%.  
The proportion of respondents who reported knowing 
their Navigator was 75.8% (1,005) while 24.3% reported 
that they did not.  The rate of respondents indicating they 
knew their Navigator varied by region between 58% and 
91%.  In the PES, patient age was captured as an ordinal 
variable and 60.9% of respondents were in the 55-74 age 
category (Table 1).  PES respondents, whether they 
reported knowing their Navigator or not, had the same age 
distribution as the overall DAP population. There were 
also no significant differences in education between those 
who knew their Navigator and those who did not.  The 
most prevalent education category was ‘high school’, 
accounting for 38.8% of those who knew their Navigator 
and 31.8% of those who did not.   
Patient Experience Ratings 
On the whole, the group of patients who knew their 
Navigator had significantly higher average ratings of 
patient experience compared with the group of patients 
who did not (91.7 compared to 81.5, t(11)=8.520, 
p<0.0001).   
 
At the regional level, there was no significant correlation 
overall between average patient experience rating scores 
and diagnostic wait times, whether at the 50th, 75th or 90th  
percentile (Table 2).  However, for the group of patients 
who did not know their Navigator, there was an inverse 
and statistically significant correlation between patient 
experience scores and wait times, measured at the 75th and 
90th percentiles (r=-0.580, p=0.04 and r=-0.590, p=0.04), 
implying that for those patients in regions with very long 
waits, there was poorer experience overall.  This 
relationship did not hold true among the group of patients 
who knew their Navigator (r=-0.430, p>0.158 at the 75th 
percentile and r=-0.389, p=0.206 at the 90th percentile) 
(see Figures 1 and 2).  
 
 
Table 1. Survey Response and Demographic Characteristics 
 
 RESPONDENTS TO THE 
QUESTION: “DID YOU KNOW 










     
TOTAL 1,005 (75.8) 320 (24.2) 1,325 (20.9) 6,327 (100) 
     
AGE     
  18 - 34 1 (0.1) 1 (0.4) 2 (0.2) 69 (1.1) 
  35 - 54 76 (7.5) 25 (10.2) 101 (8.1) 724 (12.0) 
  55 - 74 623 (61.7) 141 (57.6) 764 (60.9) 3446 (57.2) 
  75 or older 309 (30.6) 78 (31.8) 387 (30.9) 1790 (29.7) 
     
EDUCATION     
  Elementary 160 (16.1) 48 (20.1) 208 (16.9) Not collected  
  High School 385 (38.8) 76 (31.8) 461 (37.5) Not collected  
  Technical 274 (27.6) 65 (27.2) 339 (27.6) Not collected  
  Undergraduate 75 (7.6) 21 (8.8) 96 (7.8) Not collected  
  Graduate 97 (9.8) 29 (12.1) 126 (7.8) Not collected  
     
Average Patient 
Experience Score 
91.7% 81.5%  n/a 
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There were no significant relationships between regional 
DAP patient volumes and regional patient experience 
ratings, either overall (r=0.390, p=0.205), for groups of 
respondents who knew their Navigator or for groups who 





This study demonstrates that patient navigation offered 
during the diagnostic phase of the cancer journey may be 
associated with improved patient experience, especially in 
the face of long waits for diagnostic answers.  In general, 
patients who report knowing their Navigator tend to 
report higher experience scores.  These results are aligned 
with the literature, where studies demonstrate a robust 
increase in patient experience ratings and satisfaction when 
they have patient navigation support2,10.  
  
Interestingly, the results from the current study also 
demonstrate that not only are patients more satisfied and 
have a better experience when they know their Navigator, 
but factors that can negatively impact their experience may 
be allayed by the Navigator.  Specifically, patient 
navigation appears to mitigate the impact that longer wait 
times have on lowering patient experience ratings such 
that among the groups of patients who knew their 
Navigator, consistently good patient experience was seen, 
regardless of wait.  These findings are consistent with prior 
evidence suggesting that the most marked effects of 
navigation on diagnostic wait times are among patients 
with the greatest delays in their care22, 23, 24.  
 
One other factor hypothesized to impact patient 
experience in DAPs is patient volumes. However in the 
current study, regional patient volumes had no significant 
relationship with patient experience, either overall or when 
the groups were divided based on whether or not the 
patient knew their Navigator.  This suggests that the 
volume of patients in a DAP does not directly influence 
their patient experience, at least at the regional level.  
Further study is needed to determine if this result is indeed 
accurate or whether such a relationship does exist at the 
individual level but is masked by other factors not 
measured in this study.  For example, regional differences 
in the administration of DAPs and resourcing may have a 
larger impact on patient experience than overall volume.  
Additionally, since navigation has been shown to increase 
the volume of patients that a cancer center can serve while 
concurrently improving patient experience10, the true 
impact of increased patient volumes on experience may be 
obfuscated.  It is possible that once a navigation model is 
implemented and the associated improvement in patient 
experience is realized in a center, further increases to 
patient volume could begin to compromise patient 
experience at that center, particularly if no additional 
Table 2. Relationship Between Regional Diagnostic Wait Times and Patient Experience Scores, by Navigation 
Status 
 
 Navigation  
Status 
Association with Pt. Experience  
 
R*                     p-value 
Diagnostic Wait 
Times Measured 
at the 50% 
Percentile 
Navigation 0.185 0.563 
No Navigation 0.288 0.360 
All 0.007 0.982 
Diagnostic Wait 
Times Measured 
at the 75th 
Percentile 
Navigation 0.430 0.158 
No Navigation 0.580 0.044 
All 0.268 0.396 
Diagnostic Wait 
Times Measured 
at the 90th 
Percentile 
Navigation 0.389 0.206 
No Navigation 0.590 0.040 
All 0.216 0.497 
DAP Patient 
Volumes 
Navigation 0.009 0.979 
No Navigation 0.100 0.755 
All 0.390 0.205 
 
*These values are the square roots of R² values as generated using the RSQ function using median Wait Times by region and 
average question score by region. 


























*These values are the square roots of R² values as generated using the RSQ function using median Wait Times by region and
average question score by region. 
*Note: Two regions - South East and Erie St. Clair - did not have any PES data entries available in he specified time period 
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resources are allocated as volume increases.  Future 
research aimed at capturing the myriad of factors that may 
influence patient experience would be required to 
determine the relative impact of institutional factors on 
overall patient experience and how different models of 
navigation might mitigate them. 
 
Implementing a comprehensive navigation program has 
demonstrated its value in improving patient satisfaction 
and experience across the cancer journey and beyond. 
However the key factors associated with navigation that 
are responsible for maintaining good patient experience 
remain unclear.  Further work would be needed to 
understand the underlying mechanism(s) by which 
navigation is effective.  These mechanisms may include 
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education, logistical support such as reminding patients 
about their appointments or psychosocial support such as 
providing information about coping with a cancer 
diagnosis.  The key elements of navigation and the optimal 
manner in which to deliver navigational support may differ 
between patients; targeting appropriate support to those 
who would benefit most may optimize system efficiency 
and patient outcomes.  Identifying patients in need of 
more support during their diagnostic journey will help 
identify those who can benefit most from patient 
navigation.  For example, some models of navigation have 
been shown to be particularly beneficial for patients of low 
socioeconomic status, members of racial/ethnic 
minorities13, and for those who live in rural areas25.  
Evidence from a randomized clinical trial supports the 
hypothesis that navigation is most beneficial for 
disadvantaged individuals 26.  Indeed, patient navigation 
has been described as a means of addressing racial, ethnic 
and socioeconomic disparities in care 27.  Factors such as 
these disparities may serve as a way of stratifying and 
identifying patients who are in greater need of support.  
Additionally, some patients may choose to decline when 
offered navigation. One study of a lay navigation program 
found that the primary reason for declining navigation was 
that patients felt they already had a strong support system 
and did not see the need for additional support from a 
Navigator 28.  These results suggest that patients differ in 
their need or desire for psychosocial support from 
Navigators; it is reasonable that the degree to which 
Navigators can improve an individual’s patient experience 





The DAP Patient Experience Survey was designed to 
provide feedback to both Cancer Care Ontario and local 
DAPs regarding the programs’ impact on the patient 
experience and where it could be improved.  The survey is 
designed to be anonymous in order to encourage honest 
and frank feedback from patients, but this precludes data 
linkage with DAP administrative data at the patient level. 
It is possible, however, to attribute patients to the region 
in which they attended the DAP, so the data linkage and 
analyses were carried out at the regional level.  The need 
for analysis at the regional level limits our ability to make 
inferences about patient navigation at the level of the 
individual patient.  Still, hypotheses about patient-level 
effects may be generated for future testing.  The regional 
analysis also results in a smaller sample size and 
insufficient power to perform regression analysis.    
 
The comparisons that were done between the sample of 
respondents and the overall population of lung DAP 
patients suggests good representativeness of the sample 
based on the available data.  This comparison was only 
approximate because of the lag, of unknown length, 
between the time the patient visited the DAP (the date 
found in the administrative data) and when the completed 
survey was received at Cancer Care Ontario. 
 
Due to considerations of privacy and brevity, the PES did 
not include extensive detail on patient demographics or on 
actual healthcare encounters.  The only demographic data 
collected was age group and level of education and while it 
is possible that other characteristics such as gender and 
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ethnicity might also account for variations in one’s health 
experience, it was not possible to examine or control for 
their effects.  Availability of additional demographic 
features would also have enabled closer examination of the 
representativeness of the survey sample. 
 
Another limitation of the current study is the use of a 
single question (“Did you know who the Navigator was?”) 
as a proxy for patient navigation. The categorization of 
patients into those who knew their Navigator and those 
who did not was based on self-report via the PES and it is 
possible that patients used different strategies to answer 
this question. Further, the ‘dose’ of navigation that 
patients received may have differed (e.g. meeting the 
navigator once in passing versus having ongoing frequent 
consultations and support from the Navigator).  With 
respect to the sample of PES respondents, there was a 
high level of variation in the percentage of patients who 
responded to the survey between the different regions; 
thus it is possible that the data more accurately reflects 
some regions than others.  Similarly, there was a high level 
of variability between the regions in the percentage of 
survey respondents who reported knowing their 
Navigator. This may indicate that there are different 
navigation practices between regions that could not be 
accounted for in the current study, aside from the possible 
measurement biases described above.  More objective and 
precise measurement of patient navigation would help 
differentiate those who used the service from those who 
did not as well as the functional elements of navigation 




From a regional perspective, patient navigation in DAPs, 
as reflected in patients’ ability to identify their Navigator in 
the diagnostic phase of the cancer journey significantly 
improves overall patient experience. One mechanism by 
which it does so is by mitigating the ability of other factors 
- such as waiting for one’s diagnosis - to diminish the 
patient experience.  Further study is required both to 
confirm these findings at the individual level and to 
understand the specific aspects of navigation that 
positively affect DAP patient experience, in order to 
ensure that this service is provided in an optimal manner 
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Appendix 1. Questions Included in the DAP Patient Experience Survey (PES)  
 
1. Did the staff explain why you needed tests in a way you could understand?* 
2. After the tests were done, did someone explain the results in a way that you could understand?* 
3. If you had questions about your tests or test results, did you feel comfortable talking with the staff about 
them?* 
4. How often were you given confusing or conflicting information about your tests or test results?* 
5. How often did you know who to ask or where to go when you had questions about your health problems or 
your tests?* 
6. How often did you know what the next step in your care would be?* 
7. How often did you feel your care providers were aware of your medical history?* 
8. How often did you feel your care providers were aware of your test results?* 
9. Please circle the number that best describes your level of anxiety during your diagnostic testing.  
(Scale of 0 – 10)  
10. Please circle the number that best describes your level of fear during your diagnostic testing.  
(Scale of 0 – 10) 
11. Did someone at the hospital help you with your anxiety and/or fear?* 
12. Did the staff treat you with dignity and respect?* 
13. Did you feel you could trust your care providers with private information? * 
14. Did you know who the nurse navigator was?** 
15. Were you able to reach the nurse navigator whenever you had questions or concerns by phone, through e-
mail, or in person?* 
16. Did you find your experience with the navigator to be: (4 satisfaction categories provided)* 
17. What is your age?  (4 response categories provided) 
18. What is the highest level of education you have completed? (5 response categories provided)  
*  Questions included in the composite satisfaction score 
** Proxy question for navigation, used as a stratification variable 
 
 
 
 
 
 
 
 
 
 
 
